An NIH-funded study provided supporting evidence of an association between high levels of gram-negative bacteria and a stroke-, seizure-, and headache-inducing vascular abnormality.
The internal medicine resident physician at Montefiore Health System offers insight into the combined use of CGRP medications and Botox to optimize migraine prevention in patients who have inadequate response with Botox alone. 

SAP Partner Banner

About NeurologyLive's Headache & Migraine Clinical Focus page:

The NeurologyLive Headache & Migraine Clinical Focus page serves as a hub for breaking news, videos, and other resources. Items covered here include updates from the most-attended neurological conferences and annual meetings via articles and video interviews with neurology’s leading experts and key opinion leaders.
This page will always be up-to-date, providing breaking news coverage of U.S. Food and Drug Administration (FDA) approvals, key takeaways from the latest clinical trials, and notifications of recent updates to clinical guidelines for headaches and migraines. Additionally, this Clinical Focus page provides an array of condition-specific resources, like information on new and emerging therapies for migraine relief and prevention.